The first Watchman FLX Pro implantation in Hungary has been successfully completed deploying the largest 40 mm device with outstanding performance.
The implantation achieved an excellent position with optimal sealing, reinforcing the role of LAAC as a powerful alternative care strategy for patients with non-valvular atrial fibrillation who require a non-pharmacological approach to thromboembolic risk reduction.
Congratulations to Prof. Dr. László Gellér, Dr. Zoltán Salló and the outstanding team at Semmelweis University, Heart and Vascular Centre for their precision, expertise, and commitment to innovation!
#structuralheart #LAAC #WatchmanFLXPro #strokeprevention #BostonScientific #Watchman #DeliveringHealthcareSolutions #DHSHungary
